| Administration of bisphosphonates for malignant hepatic tumor with hypercalcemia. | |
| | |
MedLine Citation:
|
PMID: 22353513 Owner: NLM Status: In-Data-Review |
Abstract/OtherAbstract:
|
Background/Aims: Hypercalcemia is a paraneoplastic syndrome that is a serious condition requiring urgent treatment. We administered alendronate to hypercalcemia patients with advanced cancer with metastasized liver tumors or hepatocellular carcinoma (HCC) and then evaluated the mechanism and anticancer function of this compound. Methodology: We retrospectively studied 17 patients with hypercalcemia associated with metastatic liver tumor or HCC. Alendronate (10mg) was administered via the intravenous route for patients with metastatic liver tumor (n=12) and via the hepatic artery for patients with HCC (n=5). Results: Intravenous administration of alendronate resulted in decrease in serum calcium levels in all patients. The serum levels of tumor markers also decreased in 66.7% (8/12) of these patients. After intra-arterial alendronate administration, the serum calcium and parathyroid hormone-related protein levels decreased in all the patients. The serum levels of tumor markers such as AFP and PIVKA-II were decreased in 80% (4/5) of these patients. Electron microscopic examination of the resected hepatic tumor revealed an increase in the vascularization and formation of apoptotic vesicles in the vascular endothelial cells. Conclusions: Alendronate is effective not only for controlling hypercalcemia but also for directly enhancing the apoptosis of HCC cells. |
| | |
Authors:
|
Takatsugu Oida; Kenji Mimatsu; Hisao Kano; Atsushi Kawasaki; Youichi Kuboi; Nobutada Fukino; Kazutoshi Kida; Sadao Amano |
Related Documents
:
|
21351733 - Radiosynthesis and biological evaluation of l- and d-s-(3-[(18)f]fluoropropyl)homocyste... 20471563 - Primary myxoma of the lung. 9100183 - Effects of normo- and hypocapnic nitrous-oxide-inhalation on cerebral blood flow veloci... |
Publication Detail:
|
Type: Journal Article |
Journal Detail:
|
Title: Hepato-gastroenterology Volume: 59 ISSN: 0172-6390 ISO Abbreviation: Hepatogastroenterology Publication Date: 2012 Mar-Apr |
Date Detail:
|
Created Date: 2012-02-22 Completed Date: - Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 8007849 Medline TA: Hepatogastroenterology Country: Greece |
Other Details:
|
Languages: eng Pagination: 444-7 Citation Subset: IM |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
|
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Colonoscopic performance in a sedated health screening population: influence of colonoscope type.
Next Document: Prognostic value of the number and volume of liver tumours on portal vein embolization outcomes.